Provided by Tiger Fintech (Singapore) Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

1.36
+0.01000.74%
Post-market: 1.400.0394+2.90%18:06 EDT
Volume:38.15K
Turnover:52.13K
Market Cap:9.22M
PE:-0.43
High:1.42
Open:1.36
Low:1.33
Close:1.35
Loading ...

Intelligent Bio Solutions Q2 EPS $(0.50) Up From $(2.07) YoY, Sales $607.49K Down From $764.06K YoY

Benzinga
·
13 Feb

Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements

THOMSON REUTERS
·
13 Feb

Intelligent Bio Solutions Q2 Basic EPS USD -0.5

THOMSON REUTERS
·
13 Feb

Intelligent Bio releases shareholder letter on 2024 growth, 2025 strategy

TIPRANKS
·
10 Feb

Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy

THOMSON REUTERS
·
10 Feb

Intelligent Bio says Avon selects Intelligent Fingerprinting Drug Testing tool

TIPRANKS
·
07 Feb

Intelligent Bio Solutions Inc - Avon Freight Group Selects Inbs' Fingerprint Drug Testing for Three UK Sites

THOMSON REUTERS
·
07 Feb

Intelligent Bio Solutions : Expects Further Growth This Year, Following Its U.S. FDA 510(K) Submission in Dec 2024

THOMSON REUTERS
·
07 Feb

Intelligent Bio Solutions Expands With UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch

THOMSON REUTERS
·
07 Feb

Intelligent Bio Solutions Expects to Achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales

THOMSON REUTERS
·
06 Feb

EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales

Benzinga
·
06 Feb

Intelligent Bio announces upgrade to Intelligent Fingerprinting Drug Screening

TIPRANKS
·
31 Jan

EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites

Benzinga
·
29 Jan

Intelligent Bio Solutions partners with IVY Diagnostics

TIPRANKS
·
28 Jan

EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe's $3.6 Billion Drug Screening Market

Benzinga
·
28 Jan

Intelligent Bio Partners With Princebuild to Transition From Saliva Testing to Fingerprint Sweat-Based Drug Screening Across Its Seven UK Sites

THOMSON REUTERS
·
14 Jan

Intelligent Bio Solutions Announces 510(K) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology

THOMSON REUTERS
·
18 Dec 2024

Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET

GlobeNewswire
·
04 Dec 2024

Intelligent Bio completes method comparison study of Fingerpriinting system

TIPRANKS
·
26 Nov 2024

BRIEF-Intelligent Bio Solutions Achieves 94.1% Accuracy In Method Comparison Study

Reuters
·
26 Nov 2024